Abdool-Karim SS - Search Results

1

HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial.

Garrett NJ, Werner L, Naicker N, Naranbhai V, Sibeko S, Samsunder N, Gray C, Williamson C, Morris L, Abdool-Karim Q, Abdool-Karim SS. Garrett NJ, et al. J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):55-61. doi: 10.1097/QAI.0000000000000367. J Acquir Immune Defic Syndr. 2015. PMID: 25247433 Free PMC article. Clinical Trial.

2

Conserved domains of subtype C nef from South African HIV type 1-infected individuals include cytotoxic T lymphocyte epitope-rich regions.

Mashishi T, Loubser S, Hide W, Hunt G, Morris L, Ramjee G, Abdool-Karim S, Williamson C, Gray CM. Mashishi T, et al. AIDS Res Hum Retroviruses. 2001 Nov 20;17(17):1681-7. doi: 10.1089/088922201753342103. AIDS Res Hum Retroviruses. 2001. PMID: 11779357

3

The evolving HIV epidemic in South Africa.

Abdool-Karim Q, Abdool-Karim SS. Abdool-Karim Q, et al. Int J Epidemiol. 2002 Feb;31(1):37-40. doi: 10.1093/ije/31.1.37. Int J Epidemiol. 2002. PMID: 11914290 No abstract available.

4

Vertical HIV transmission in South Africa: translating research into policy and practice.

Abdool Karim S, Abdool Karim Q, Adhikari M, Cassol S, Chersich M, Cooper P, Coovadia A, Coovadia H, Cotton M, Coutsoudis A, Hide W, Hussey G, Maartens G, Madhi S, Martin D, Pettifor JM, Rollins N, Sherman G, Thula S, Urban M, Velaphi S, Williamson C. Abdool Karim S, et al. Lancet. 2002 Mar 23;359(9311):992-3. doi: 10.1016/s0140-6736(02)08063-7. Lancet. 2002. PMID: 11937176 No abstract available.

5

Antiretroviral therapy: challenges and options in South Africa.

Abdool Karim SS, Abdool Karim Q, Baxter C. Abdool Karim SS, et al. Lancet. 2003 Nov 1;362(9394):1499. doi: 10.1016/S0140-6736(03)14700-9. Lancet. 2003. PMID: 14602450 No abstract available.

6

Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care.

Abdool-Karim SS, Abdool-Karim Q, Friedland G, Lalloo U, El-Sadr WM; START project. Abdool-Karim SS, et al. AIDS. 2004 Apr 30;18(7):975-9. doi: 10.1097/00002030-200404300-00004. AIDS. 2004. PMID: 15096799 Review. No abstract available.

7

Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.

Friedland G, Abdool Karim S, Abdool Karim Q, Lalloo U, Jack C, Gandhi N, El Sadr W. Friedland G, et al. Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S421-8. doi: 10.1086/421407. Clin Infect Dis. 2004. PMID: 15156433

8

Global epidemiology of HIV-AIDS.

Abdool Karim SS, Abdool Karim Q, Gouws E, Baxter C. Abdool Karim SS, et al. Infect Dis Clin North Am. 2007 Mar;21(1):1-17, vii. doi: 10.1016/j.idc.2007.01.010. Infect Dis Clin North Am. 2007. PMID: 17502227

9

Diverse approaches useful for microbicide trials.

Abdool Karim SS, Abdool Karim Q. Abdool Karim SS, et al. Nature. 2007 Sep 6;449(7158):24. doi: 10.1038/449024c. Nature. 2007. PMID: 17805274 No abstract available.

10

The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection.

Moore PL, Gray ES, Choge IA, Ranchobe N, Mlisana K, Abdool Karim SS, Williamson C, Morris L; CAPRISA 002 Study Team. Moore PL, et al. J Virol. 2008 Feb;82(4):1860-9. doi: 10.1128/JVI.02187-07. Epub 2007 Dec 5. J Virol. 2008. PMID: 18057243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters